This Government Contract opportunity from Department Of Health And Human Services was posted on May 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Cryogenic Storage of cGMP Grade Cell Banks
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Centers for Disease Control and Prevention (CDC) plans to award a firm-fixed price, sole-source purchase order to BioReliance Solutions for the continued cGMP-compliant cryogenic storage and maintenance of qualified Master Cell Banks (MCBs) and Working Cell Banks (WCBs) consisting of Vero, MDCK, and Expi293F™ cell lines critical for influenza vaccine development through the National Center for Immunization and Respiratory Diseases (NCIRD). This contract, conducted under FAR Part 13 - Simplified Acquisition Procedures, is justified solely on the basis that BioReliance is the only source capable of maintaining the existing cell banks without requiring transfer, which would risk thermal stress, contamination, viability loss, and disruption of chain-of-custody documentation in violation of FDA regulatory guidance. The services demand uninterrupted storage in continuously monitored liquid nitrogen or colder cryogenic systems, secure environmental monitoring, full documentation to meet FDA and cGMP standards, and the ability to support both current and future vaccine programmatic requirements. The procurement includes a base year plus four option years, with the place of performance at BioReliance’s facility in Rockville, Maryland. This acquisition excludes competitive solicitation and does not request formal proposals but invites capability statements from eligible small businesses, although responses will not trigger competition unless the government elects otherwise. The contract emphasizes strict adherence to regulatory compliance, secure handling of biological materials, and preservation of cell bank integrity essential to ongoing public health efforts. The contracting officer is Debra Baker, with technical oversight by CDC program analysts, and the government intends to award within 15 days of the notice closing date. No detailed pricing information, contract clauses, or OCI mitigation plans are provided, reflecting the unique operational and regulatory nature of this sole-source acquisition.
General Info
Agency
NAICS
Place of Performance
Rockville, MD, 20850, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a notice of intent to sole source for cGMP cell bank storage. This notice is not a request for competitive quotes. BioReliance Solutions is the service provider. However, any available small businesses (e.g., 8(a), service-disabled veteran owned small business, HUBZone small business, small disadvantaged business, veteran-owned small business, and women-owned small business) as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.
A determination by the Government to compete this proposed award based upon responses to this notice is solely within the discretion of the Government. A solicitation document will not be issued and quotations will not be requested.
The Center for Disease Control and Prevention intends to award a fixed price purchase order, on a firm fixed price sole source award basis to provide cGMP cryostorage to four Influenza Division cell banks: the MCB and WCB for three types of qualified cells: Vero cells, MDCK cells, and Expi293F cells for National Center for Immunization and Respiratory Disease (NCIRD).
The purpose of this acquisition is to ensure the continued cGMP-compliant cryogenic storage, maintenance, and secure management of CDC-qualified Master Cell Banks (MCBs) and Working Cell Banks (WCBs) that support the development and production of CVVs. This effort involves coordination between the Centers for Disease Control and Prevention (CDC) Influenza Division and a qualified contractor capable of meeting all applicable FDA, cGMP, and regulatory requirements for the long-term storage of regulated biological materials.
The scope of this contract is the continued cryogenic storage and maintenance of CDC’s qualified cell banks under cGMP conditions. The contractor shall store the designated Master Cell Banks (MCBs) and Working Cell Banks (WCBs) for the Vero, MDCK, and Expi293F™ cell lines in validated continuously monitored liquid nitrogen or colder cryogenic systems. The contractor shall ensure long-term viability and integrity throughout the period of performance.
The overall objective is to maintain uninterrupted, regulatory-compliant cryostorage services for multiple CDC cell substrates, including Vero, MDCK, and Expi293F™ cell lines, all of which are essential for generating seasonal and pandemic influenza CVVs. The Contractor shall ensure compliance with all applicable FDA regulations, cGMP requirements, provide secure, monitored, and validated cryogenic storage conditions, security controls, and documentation standards necessary to preserve material integrity and support FDA-regulated vaccine manufacturing processes. The contractor must be capable of supporting both current and future programmatic needs, ensuring that CDC’s characterized and qualified cell banks remain viable, traceable, and immediately accessible for vaccine manufacturing workflows.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT),which allows contracting officers to solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Only one award will be made as a result of this notice. This will be awarded as a firm-fixed price purchase order.
The period of performance for this requirement will be a Base year and four 12 months option years. The North American Industry Classification (NAICS) code for this acquisition is 493120 Cold Storage Locker Services,(www.census.gov/naics
This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government plans to award a contract for this requirement within 15 days of this notice.
Comments to this announcement, referencing this posting number, may be submitted to the CDC, Office of Acqusition Services (OAS), prior to the closing date specified in this announcement, to the attention of Debra Baker, Contracing Officer via email to xvv9@cdc.gov by May 22, 2026 at 3pm EST.